Four pediatric patients with autosomal recessive polycystic kidney disease developed new-onset diabetes after renal transplantation

Pediatric Transplantation

Volumn 18, Issue 7, 2014, Pages 698-705

  Carter, S A ^a   Kitching, A R ^a,b   Johnstone, L M ^a  

^a SOUTHERN HEALTH   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Autosomal recessive polycystic kidney disease; New onset diabetes after transplantation; Pediatrics; Renal transplant

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CYCLOSPORIN; METHYLPREDNISOLONE; PREDNISOLONE; TACROLIMUS;

ADOLESCENT; ARTICLE; CASE REPORT; CHILD; DIABETES MELLITUS; FEMALE; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY GRAFT REJECTION; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; MALE; NEW ONSET DIABETES AFTER RENAL TRANSPLANTATION; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PREVALENCE; RISK FACTOR; SCHOOL CHILD; SCREENING TEST; ADVERSE EFFECTS; COMPLICATION; POLYCYSTIC KIDNEY, AUTOSOMAL RECESSIVE; POSTOPERATIVE COMPLICATION; REGISTER; RENAL INSUFFICIENCY; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MALE; POLYCYSTIC KIDNEY, AUTOSOMAL RECESSIVE; POSTOPERATIVE COMPLICATIONS; REGISTRIES; RENAL INSUFFICIENCY; RISK FACTORS; TREATMENT OUTCOME;

EID: 84926178339     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/petr.12332     Document Type: Article

References (52)

1. PROKAI A, FEKETE A, KIS E., et al. Post-transplant diabetes mellitus in children following renal transplantation. Pediatr Transplant 2008: 12: 643-649.
2. YATES CJ, FOURLANOS S, HJELMESAETH J., COLMAN PG, COHNEY SJ. New-onset diabetes after kidney transplantation - Changes and challenges. Am J Transplant 2012: 12: 820-828.
3. GHISDAL L, Van LAECKE S, ABRAMOWICZ MJ, VANHOLDER R, ABRAMOWICZ D. New-onset diabetes after renal transplantation: Risk assessment and management. Diabetes Care 2012: 35: 181-188.
4. SARNO G, MUSCOQIURI G, De ROSA P. New-onset diabetes after kidney transplantation: Prevalence, risk factors, and management. Transplantation 2012: 93: 1189-1195.
5. DAVIDSON J, WILKINSON A, DANTAL J., et al. New-onset diabetes after transplantation: 2003 international consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. Transplantation 2003: 75: SS3-24.
6. SHISHIDO S, SATO H, ASANUMA H., et al. Unexpectedly high prevalence of pretransplant abnormal glucose tolerance in pedi-atric kidney transplant recipients. Pediatr Transplant 2006: 10: 67-73.
7. BUYAN N, BILGE I, TURKMEN M.A., et al. Post-transplant glucose status in 61 pediatric renal transplant recipients: Preliminary results of five Turkish pediatric nephrology centers. Pediatr Transplant 2010: 14: 203-211.
8. AL-UZRI A, STABLEIN DM, A COHN R. Posttransplant diabetes mellitus in pediatric renal transplant recipients: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Transplantation 2001: 72: 1020-1024.
9. BURROUGHS TE, SWINDLE JP, SALVALAGGIO P.R., et al. Increasing incidence of new-onset diabetes after transplant among pediatric renal transplant patients. Transplantation 2009: 88: 367-373.
10. GREENSPAN LC, GITELMAN SE, LEUNG M.A., GLIDDEN DV, MATHIAS RS. Increased incidence in post-transplant diabetes mellitus in children: A case-control analysis. Pediatr Nephrol 2002: 17: 1-5.
11. KUO HT, POOMMIPANIT N, SAMPAIO M., REDDY P, CHO YW, BUNNAPRADIST S. Risk factors for development of new-onset diabetes mellitus in pediatric renal transplant recipients: An analysis of the OPTN/UNOS database. Transplantation 2010: 89: 434-439.
12. COTELLESSA M, PASTORINO N, CRESTA L., et al. Diabetes mell-itus after kidney transplantation in pediatric recipients. Pediatr Nephrol 2003: 18: 1315-1316.
13. KOSHY SM, GUTTMANN A, HEBERT D., PARKES RK, LOGAN AG. Incidence and risk factors for cardiovascular events and death in pediatric renal transplant patients: A single center long-term outcome study. Pediatr Transplant 2009: 13: 1027-1033.
14. WEBSTER AC, WOODROFFE RC, TAYLOR R.S., CHAPMAN JR, CRAIG JC. Tacrolimus versus cyclosporin as primary immuno-suppression for kidney transplant recipients: Meta-analysis and meta-regression of randomised trial data. BMJ 2005: 331: 810.
15. PROKAI A, FEKETE A, PASTI K., et al. The importance of different immunosuppressive regimens in the development of post-transplant diabetes mellitus. Pediatr Diabetes 2012: 13: 81-91.
16. BEE YM, TAN HC, TAY T.L., KEE TY, GOH SY, KEK PC. Incidence and risk factors for development of new-onset diabetes after kidney transplantation. Ann Acad Med Singapore 2011: 40: 160-167.
17. HEARN T, SPALLUTO C, PHILLIPS V.J., et al. Subcellular localization of ALMS1 supports involvement of centrosome and basal body dysfunction in the pathogenesis of obesity, insulin resistance, and type 2 diabetes. Diabetes 2005: 54: 1581-1587.
18. IMHOFF O, MARION V, STOETZEL C., et al. Bardet-Biedl syndrome: A study of the renal and cardiovascular phenotypes in a French cohort. Clin J Am Soc Nephrol 2011: 6: 22-29.
19. VAREESANGTHIP K, TONG P, WILKINSON R., THOMAS TH. Insulin resistance in adult polycystic kidney disease. Kidney Int 1997: 52: 503-508.
20. SENEE V, CHELALA C, DUCHATELET S., et al. Mutations in GLIS3 are responsible for a rare syndrome with neonatal diabetes mellitus and congenital hypothyroidism. Nat Genet 2006: 38: 682-687.
21. TAHA D, BARBAR M, KANAAN H., WILLIAMSON BALFE J. Neonatal diabetes mellitus, congenital hypothyroidism, hepatic fibrosis, polycystic kidneys, and congenital glaucoma: A new autosomal recessive syndrome? Am J Med Genet A 2003: 122A: 269-273.
22. PIETRZAK-NOWACKA M, SAFRANOW K, BYRA E., NOWOSIAD M, MARCHELEK-MYSLIWIEC M, CIECHANOWSKI K. Glucose metabolism parameters during an oral glucose tolerance test in patients with autosomal dominant polycystic kidney disease. Scand J Clin Lab Invest 2010: 70: 561-567.
23. RUDERMAN I, MASTERSON R, YATES C., GORELIK A, COHNEY SJ, WALKER RG. New onset diabetes after kidney transplantation in autosomal dominant polycystic kidney disease: A retrospective cohort study. Nephrology 2012: 17: 89-96.
24. PIETRZAK-NOWACKA M, SAFRANOW K, ROZANSKI J., et al. Autosomal dominant polycystic kidney disease is not a risk factor for post-transplant diabetes mellitus. Matched-pair design multicenter study. Arch Med Res 2008: 39: 312-319.
25. BALGRADEAN M, CINTEZA E, FERECHIDE D. Post renal transplant type 2 diabetes mellitus in a case of familial juvenile nephrophthisis. Maedica 2013: 8: 26-29.
26. MATHEW JT, RAO M, JOB V., RATNASWAMY S, JACOB CK. Post-transplant hyperglycaemia: A study of risk factors. Nephrol Dial Transplant 2003: 18: 164-171.
27. ERICE E, LLOP E, BERZIGOTTI A., et al. Insulin resistance in patients with cirrhosis and portal hypertension. Am J Physiol Gastrointest Liver Physiol 2012: 302: G1458-1465.
28. PICARDI A, DAVOLA D, GENTILUCCI U.V., et al. Diabetes in chronic liver disease: From old concepts to new evidence. Diabetes Metab Res Rev 2006: 22: 274-283.
29. PETRIDES AS, RIELY CA, DEFRONZO RA. Insulin resistance in noncirrhotic idiopathic portal hypertension. Gastroenterology 1991: 100: 245-251.
30. PETRIDES AS, GROOP LC, RIELY C.A., DEFRONZO RA. Effect of physiologic hyperinsulinemia on glucose and lipid metabolism in cirrhosis. J Clin Investig 1991: 88: 561-570.
31. SHMUELI E, MIELL JP, STEWART M, ALBERTI K.G., RECORD CO. High insulin-like growth factor binding protein 1 levels in cirrhosis: Link with insulin resistance. Hepatology (Baltimore, MD) 1996: 24: 127-133.
32. HWANG DL, HUANG SP, LAN W.S., LEE PD. Elevated insulin, proinsulin and insulin-like growth factor-binding protein-1 in liver disease. Growth Horm IGF Res 2003: 13: 316-321.
33. DOMINICI FP, TURYN D. Growth hormone-induced alterations in the insulin-signaling system. Exp Biol Med (Maywood, NJ) 2002: 227: 149-157.
34. HALDORSEN IS, VESTERHUS M, RAEDER H., et al. Lack of pancreatic body and tail in HNF1B mutation carriers. Diabet Med 2008: 25: 782-787.
35. EDGHILL EL, BINGHAM C, SLINGERLAND A.S., et al. Hepatocyte nuclear factor-1 beta mutations cause neonatal diabetes and intrauterine growth retardation: Support for a critical role of HNF-1beta in human pancreatic development. Diabet Med 2006: 23: 1301-1306.
36. WANG L, COFFINIER C, THOMAS M.K., et al. Selective deletion of the Hnf1beta (MODY5) gene in beta-cells leads to altered gene expression and defective insulin release. Endocrinology 2004: 145: 3941-3949.
37. KITANAKA S, SATO U, IGARASHI T. Regulation of human insulin, IGF-I, and multidrug resistance protein 2 promoter activity by hepatocyte nuclear factor (HNF)-1beta and HNF-1alpha and the abnormality of HNF-1beta mutants. J Endocrinol 2007: 192: 141-147.
38. GRESH L, FISCHER E, REIMANN A., et al. A transcriptional network in polycystic kidney disease. EMBO J 2004: 23: 1657-1668.
39. IGARASHI P, SHAO X, MCNALLY B.T., HIESBERGER T. Roles of HNF-1beta in kidney development and congenital cystic diseases. Kidney Int 2005: 68: 1944-1947.
40. KANG HS, BEAK JY, KIM Y.S., HERBERT R., JETTEN AM. Glis3 is associated with primary cilia and Wwtr1/TAZ and implicated in polycystic kidney disease. Mol Cell Biol 2009: 29: 2556-2569.
41. KIM YS, NAKANISHI G, LEWANDOSKI M., JETTEN AM. GLIS3, a novel member of the GLIS subfamily of Kruppel-like zinc finger proteins with repressor and activation functions. Nucleic Acids Res 2003: 31: 5513-5525.
42. KIM YS, KANG HS, HERBERT R, et al. Kruppel-like zinc finger protein Glis2 is essential for the maintenance of normal renal functions. Mol Cell Biol 2008: 28: 2358-2367.
43. KANG HS, KIM YS, ZERUTH G, et al. Transcription factor Glis3, a novel critical player in the regulation of pancreatic beta-cell development and insulin gene expression. Mol Cell Biol 2009: 29: 6366-6379.
44. ATTANASIO M, UHLENHAUT NH, SOUSA V.H., et al. Loss of GLIS2 causes nephronophthisis in humans and mice by increased apoptosis and fibrosis. Nat Genet 2007: 39: 1018-1024.
45. RAMACHANDRAN H, SCHAFER T, KIM Y., et al. Interaction with the Bardet-Biedl gene product TRIM32/BBS11 modifies the half-life and localization of Glis2/NPHP7. J Biol Chem 2014: 289: 8390-8401.
46. BARRETT JC, CLAYTON DG, CONCANNON P, et al. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 2009: 41: 703-707.
47. BARKER A, SHARP SJ, TIMPSON N.J., et al. Association of genetic loci with glucose levels in childhood and adolescence: A meta-analysis of over 6, 000 children. Diabetes 2011: 60: 1805-1812.
48. BUTANI L, MAKKER SP. Conversion from tacrolimus to neoral for postrenal transplant diabetes. Pediatr Nephrol 2000: 15: 176-178.
49. HJELMESAETH J, HARTMANN A, LEIVESTAD T., et al. The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events. Kidney Int 2006: 69: 588-595.
50. BURROUGHS TE, SWINDLE J, TAKEMOTO S., et al. Diabetic complications associated with new-onset diabetes mellitus in renal transplant recipients. Transplantation 2007: 83: 1027-1034.
51. KIBERD M, PANEK R, KIBERD BA. New onset diabetes mellitus post-kidney transplantation. Clin Transplant 2006: 20: 634-639.
52. COSIO FG, PESAVENTO TE, KIM S, OSEI K., HENRY M, FERGUSON RM. Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. Kidney Int 2002: 62: 1440-1446.